4.5 Article

Intracellular oxidation of allopregnanolone by human brain type 10 17beta-hydroxysterold dehydrogenase

期刊

BRAIN RESEARCH
卷 1040, 期 1-2, 页码 29-35

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.brainres.2005.01.022

关键词

neuroactive steroid; neurosteroidogenesis; modulator of GABA(A) receptors; astrocyte; Alzheimer's disease; Down's syndrome

向作者/读者索取更多资源

Allopregnanolone is a positive allosteric modulator of GABA(A) receptors, generated by the reduction of 5 alpha-dihydroprogesterone (5 alpha-DHP) in astrocytes. This neuroactive steroid can be inactivated by its 3 alpha-oxidation to yield 5 alpha-DHP. It was found that 5 alpha-DHP levels in HEK293 cells expressing type 10 17 beta-hydroxysteroid dehydrogenase (17 beta-HSD10), but not its catalytic inactive mutant, increased significantly as allopregnanolone was added to culture media. The results demonstrate that mitochondrial 17 beta-HSD10 effectively catalyzes the intracellular oxidation of allopregnanolone. Moreover, brain astrocytes contain a moderate level of 17 beta-HSD10, which is elevated in activated astrocytes of brains with Alzheimer type pathology, including sporadic Alzheimer's disease (AD) and Down's syndrome with AD. The distribution of 17 beta-HSD10 was found not to parallel that of 3 alpha-HSD3. Cerebral cortex has the lowest level of 17 beta-HSD10; whereas the hippocampus, hypothalamus, and amygdala possess relatively higher levels of this enzyme. The catalysis of 17 beta-HSD10 appears to be essential for maintaining normal functions of GABAergic neurons. The elevated level of 17 beta-HSD10 in activated astrocytes is a new feature found in brains of people with AD, and it may have important impact on AD pathogenesis. (c) 2005 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据